Quest 10 Wealth Builders’s GSK GSK Stock Holding History

Quest 10 Wealth Builders’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.5K	Hold	239	–	–	0.01%	410
2026 Q1	$13.2K	Sell	239 -18	-7%	-$975	0.01%	404
2025 Q4	$12.6K	Sell	257 -7	-3%	-$326	0.01%	379
2025 Q3	$11.4K	Sell	264 -1	-0.4%	-$39	0.01%	365
2025 Q2	$10.2K	Buy	265 +25	+10%	+$955	0.01%	397
2025 Q1	$9.28K	Sell	240 -56	-19%	-$2.05K	0.01%	373
2024 Q4	$10K	Buy	+296	New	+$10.7K	0.01%	396

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Quest 10 Wealth Builders's GSK Position: Q2 2026 in Review

Quest 10 Wealth Builders held its GSK (GSK) position steady in Q2 2026 at 239 shares worth $12.5K. The position accounts for 0.01% of the portfolio, ranked #410.

Quest 10 Wealth Builders first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $13.2K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Quest 10 Wealth Builders held 239 shares of GSK worth $12.5K as of Q2 2026.
Quest 10 Wealth Builders left its GSK share count unchanged in Q2 2026.
GSK made up 0.01% of Quest 10 Wealth Builders's portfolio in Q2 2026, its #410 holding.
Quest 10 Wealth Builders first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
Quest 10 Wealth Builders's GSK position peaked at $13.2K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.